98566141 - AJ AJINOMOTO

Information

• Trademark
• 98566141

• Source

• Serial Number

  98566141

• International Classifications

  • 40 - Treatment of materials
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  May 23, 2024
  7 months ago

• Transaction Date

  January 11, 2025
  3 days ago

• Status Date

  January 10, 2025
  4 days ago

• Location Date

  December 25, 2024
  20 days ago

• First Use Anywhere Date

  October 02, 2017
  7 years ago

• First Use In Commerce Date

  February 26, 2018
  6 years ago

• Status Code

  680

• Current Location

  TMO LAW OFFICE 118

  Employee Name

  DUBRAY, KATHERINE

• Attorney Docket Number

  03328.1269-1

  Attorney Name

  Mark Sommers

  Law Office Assigned Location Code

  M90

• Owners

  • AJINOMOTO CO., INC.

Case File Statements

• GS0401: Custom synthesis and manufacture of peptides; Custom synthesis and manufacture of proteins; Custom synthesis and manufacture of antibody; Custom synthesis and manufacture of antibody-drug conjugate.
• DM0000: The mark consists of the stylized letters "AJ AJINOMOTO" in red with the letters "AJ" appearing centered above "AJINOMOTO".
• PM0001: AJ AJI-NO-MOTO
• CC0000: The color(s) red is/are claimed as a feature of the mark.
• TR0000: The English translation of "AJINOMOTO" in the mark is the essence of taste.
• GS0421: Laboratory, pilot plant and commercial production scale process design of the synthesis and manufacture of peptides for third parties; Analysis services concerning the synthesis and manufacture of peptide for third parties; Laboratory, pilot plant and commercial production scale process design of the synthesis and manufacture of proteins for third parties; Analysis services concerning the synthesis and manufacture of proteins for third parties; Laboratory, pilot plant and commercial production scale process design of the synthesis and manufacture of antibody for third parties; Analysis services concerning the synthesis and manufacture of antibody for third parties; Laboratory, pilot plant and commercial production scale process design of the synthesis and manufacture of antibody-drug conjugate for third parties; Analysis services concerning the synthesis and manufacture of antibody-drug conjugate for third parties.

Case File Event Statements

• 5/23/2024 - 7 months ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 12/1/2024 - a month ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 12/8/2024 - a month ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 12/16/2024 - 29 days ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 12/16/2024 - 29 days ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 12/16/2024 - 29 days ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 12/25/2024 - 20 days ago

  9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 12/25/2024 - 20 days ago

  8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 12/25/2024 - 20 days ago

  7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 1/10/2025 - 4 days ago

  10 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA